[DOI] [PMC free article] [PubMed] [Google Scholar] 26.Moreno-Fernndez S., Garcs-Rimn M., Vera G., Astier J., Landrier J.F., Miguel M
That is approaching tirzepatide territory, particularly considering the shorter trial duration
Chronic ketamine exposure in rodent models (50 mg/kg daily for 8 weeks) leads to significant activation of microglial cells and elevated expression of proinflammatory cytokines, such as IL-6 and IL-1, which correlate with hippocampal neuronal damage (Yin et al., 2022)
On April 9, 2025, your firm committed to recall the products within expiry
More GLP-1 options are coming for federal retirees, but they come with a catch A new Medicare program launching July 1 broadens access to drugs like Zepbound and Foundayo, but federal annuitants need to know how the $50 copay will affect their catastrophic limits